Comparison of pemetrexed plus cisplatin with gemcitabine plus docetaxel in refractory/metastatic osteosarcoma: Clinical outcomes from a retrospective database monitored in a single institute. [electronic resource]
Publication details: Oncology letters Nov 2014Description: 2243-2248 p. digitalISSN:- 1792-1074
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.